Evidence map›Paper›PMID 35499796›Full record

ReviewMolecular neurobiology2022

A Literature Review of Traumatic Brain Injury Biomarkers.

Hazem S Ghaith, Asmaa Ahmed Nawar, Mohamed Diaa Gabra, Mohamed Essam Abdelrahman, Mohamed H Nafady, Eshak I Bahbah, Mahmoud Ahmed Ebada, Ghulam Md Ashraf, Ahmed Negida, George E Barreto

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 4 pooled it
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 4 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Nanozyme-based therapeutic strategies for traumatic brain injury.International journal of pharmaceutics: X · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Research progress on biomarkers of traumatic brain injury.Animal models and experimental medicine · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Multi-dimensional plasma proteomic profiling elucidates molecular mechanisms and pathophysiological networks in pediatric severe traumatic brain injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  18. Review
  19. PredictiveACS omega · 2026
    Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Hazem S GhaithFaculty of Medicine, Al Azhar University, Cairo, Egypt.
Asmaa Ahmed NawarFaculty of Medicine, Zagazig University, Zagazig, Egypt.
Mohamed Diaa GabraFaculty of Medicine, South Valley University, Qena, Egypt.
Mohamed Essam AbdelrahmanFaculty of Medicine, South Valley University, Qena, Egypt.
Mohamed H NafadyFaculty of Applied Medical Science, Misr University for Science and Technology, First 6th of October, Egypt.
Eshak I BahbahFaculty of Medicine, Al-Azhar University, New Damietta, Egypt.
Mahmoud Ahmed EbadaFaculty of Medicine, Zagazig University, Zagazig, Egypt.
Ghulam Md AshrafPre-clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed NegidaFaculty of Medicine, Zagazig University, Zagazig, Egypt. ahmed.said.negida@gmail.com.
George E BarretoDepartment of Biological Sciences, University of Limerick, Limerick, Ireland. George.Barreto@ul.ie.ORCID http://orcid.org/0000-0002-6644-1971
Zagazig University · EGAl-Azhar University · EGSouth Valley University · EGKing Abdulaziz University · SAMisr University for Science and Technology · EGUniversity of Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research into TBI biomarkers has accelerated rapidly in the past decade owing to the heterogeneous nature of TBI pathologies and management, which pose challenges to TBI evaluation, management, and prognosis. TBI biomarker proteins resulting from axonal, neuronal, or glial cell injuries are widely used and have been extensively studied. However, they might not pass the blood-brain barrier with sufficient amounts to be detected in peripheral blood specimens, and further might not be detectable in the cerebrospinal fluid owing to flow limitations triggered by the injury itself. Despite the advances in TBI research, there is an unmet clinical need to develop and identify novel TBI biomarkers that entirely correlate with TBI pathologies on the molecular level, including mild TBI, and further enable physicians to predict patient outcomes and allow researchers to test neuroprotective agents to limit the extents of injury. Although the extracellular vesicles have been identified and studied long ago, they have recently been revisited and repurposed as potential TBI biomarkers that overcome the many limitations of the traditional blood and CSF assays. Animal and human experiments demonstrated the accuracy of several types of exosomes and miRNAs in detecting mild, moderate, and severe TBI. In this paper, we provide a comprehensive review of the traditional TBI biomarkers that are helpful in clinical practice. Also, we highlight the emerging roles of exosomes and miRNA being the promising candidates under investigation of current research.

Indexed as

Brain Injuries, TraumaticExosomesAnimalsBiomarkersNeurogliaNeuronsBiomarkersBiomarkersExosomesHead injurymiRNATraumatic brain injury

Identifiers

PMID35499796
PMCPMC9167167
OpenAlexW4225281672

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.